Chk1 C-terminal regulatory phosphorylation mediates checkpoint activation by de-repression of Chk1 catalytic activity.
- Published in:
- Oncogene, 2009, v. 28, n. 24, p. 2314, doi. 10.1038/onc.2009.102
- By:
- Publication type:
- Article
Works matching IS 09509232 AND DT 2009 AND VI 28 AND IP 24
Results: 6
1
2
Tie2-mediated multidrug resistance in malignant gliomas is associated with upregulation of ABC transporters.
- Published in:
- Oncogene, 2009, v. 28, n. 24, p. 2358, doi. 10.1038/onc.2009.103
- By:
- Publication type:
- Article
3
Kinase drug discovery approaches in chronic myeloproliferative disorders.
- Published in:
- Oncogene, 2009, v. 28, n. 24, p. 2305, doi. 10.1038/onc.2009.107
- By:
- Publication type:
- Article
4
Phosphoproteomic analysis of Syk kinase signaling in human cancer cells reveals its role in cell–cell adhesion.
- Published in:
- Oncogene, 2009, v. 28, n. 24, p. 2337, doi. 10.1038/onc.2009.99
- By:
- Publication type:
- Article
5
PUMA mediates EGFR tyrosine kinase inhibitor-induced apoptosis in head and neck cancer cells.
- Published in:
- Oncogene, 2009, v. 28, n. 24, p. 2348, doi. 10.1038/onc.2009.108
- By:
- Publication type:
- Article
6
Blockade of Cripto binding to cell surface GRP78 inhibits oncogenic Cripto signaling via MAPK/PI3K and Smad2/3 pathways.
- Published in:
- Oncogene, 2009, v. 28, n. 24, p. 2324, doi. 10.1038/onc.2009.97
- By:
- Publication type:
- Article